Back to search

Article

Cooperative Genomic Lesions in HRAS-Mutant Cancers Predict Resistance to Farnesyltransferase Inhibitors

2023-07-14

Abstract excerpt

<title>Abstract</title> <p>The clinical development of farnesyltransferase inhibitors (FTI) for <italic>HRAS</italic>-mutant tumors showed mixed responses dependent on cancer type. Co-occurring mutations may affect response. We aimed to uncover cooperative genetic events specific to <italic>HRAS</italic>-mutant tumors and study their effect on FTI sensitivity. Using targeted sequencing data from MSK-IMPACT and DF...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
81ff3949-6fdc-5972-8fa1-931ace0da04a
DOI
10.21203/rs.3.rs-3154719/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Cooperative Genomic Lesions in HRAS-Mutant Cancers Predict Resistance to Farnesyltransferase InhibitorsDOI 10.21203/rs.3.rs-3154719/v1
Select a neighboring publication to make it the new centre.